mogamulizumab

Italy

Drugs containing this active substance

  • POTELIGEO

    This medicine is used to treat adults with mycosis fungoides and Sézary syndrome, two types of skin cancers called cutaneous T-cell lymphomas, in patients who have already received at least one other treatment by mouth or by injection.

    Form: solution for infusion, concentrate

    Active substance Dosage
    mogamulizumab -

    ATC: L01FX09

    Manufacturer: KYOWA KIRIN HOLDINGS B.V.